Shire PLC Company Profile (LON:SHP)

About Shire PLC

Shire PLC logoShire plc is a biotech company. The Company, along with its subsidiaries, is engaged in developing and marketing medicines for patients with rare diseases and other select conditions. The Company operates in the segment of research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. The Company's products include VYVANSE/VENVANSE/ELVANSE/TYVENSE/ELVANSEVUXEN/ADUVANZ (lisdexamfetamine dimesylate), ADDERALL XR (mixed salts of a single-entity amphetamine), INTUNIV (extended release guanfacine), LIALDA (mesalamine)/MEZAVANT(mesalazine), PENTASA (mesalamine), REPLAGAL (agalsidase alfa), ELAPRASE (idursulfase), VPRIV (velaglucerase alfa), FIRAZYR (icatibant), FOSRENOL (lanthanum carbonate), KALBITOR, CINRYZE C1 esterase inhibitor (human), GATTEX/REVESTIVE, BUMINATE 25% Albumin (Human), BUMINATE 5% Albumin (Human), GLASSIA Alpha1-Proteinase Inhibitor (Human) and ONCASPAR pegaspargase.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: SHP
  • CUSIP:
Key Metrics:
  • Previous Close: $66.06
  • 50 Day Moving Average: $4983.22
  • 200 Day Moving Average: $4511.67
  • 52-Week Range: GBX 2,707.19 - GBX 5,377
  • Trailing P/E Ratio: 31.16
  • P/E Growth: 0.00
  • Market Cap: $34.13B
  • Outstanding Shares: 682,799,000
Additional Links:

Analyst Ratings

Consensus Ratings for Shire PLC (LON:SHP) (?)
Ratings Breakdown: 1 Sell Rating, 1 Hold Rating, 16 Buy Ratings, 1 Strong Buy Rating
Consensus Rating:Buy (Score: 2.89)
Consensus Price Target: GBX 5,828

Analysts' Ratings History for Shire PLC (LON:SHP)
Show:
DateFirmActionRatingPrice TargetDetails
9/30/2016BNP ParibasReiterated RatingOutperformGBX 5,900View Rating Details
9/29/2016Goldman Sachs Group Inc.Reiterated RatingConviction-BuyGBX 6,300View Rating Details
9/28/2016Shore CapitalReiterated RatingBuyView Rating Details
9/28/2016HSBCLower Price Target HoldGBX 5,250 -> GBX 5,200View Rating Details
9/27/2016Berenberg BankReiterated RatingBuyGBX 5,800View Rating Details
9/27/2016Citigroup Inc.Reiterated RatingBuyView Rating Details
9/23/2016JPMorgan Chase & Co.Reiterated RatingOverweightView Rating Details
9/19/2016Deutsche Bank AGReiterated RatingBuyGBX 6,000View Rating Details
9/19/2016Liberum CapitalReiterated RatingBuyGBX 5,500View Rating Details
9/12/2016Jefferies GroupReiterated RatingBuyGBX 6,600View Rating Details
8/3/2016Credit Suisse Group AGBoost Price TargetOutperformGBX 5,000 -> GBX 5,200View Rating Details
8/3/2016Royal Bank Of CanadaReiterated RatingOutperformView Rating Details
6/3/2016Morgan StanleyReiterated RatingOverweightGBX 5,600View Rating Details
3/15/2016Sanford C. BernsteinReiterated RatingOutperformGBX 5,000View Rating Details
3/10/2016AlphaValueReiterated RatingBuyGBX 6,420View Rating Details
1/12/2016S&P Equity ResearchReiterated RatingBuyView Rating Details
1/5/2016Barclays PLCReiterated RatingOverweightGBX 5,700View Rating Details
12/3/2015InvestecDowngradeSellView Rating Details
11/3/2015Kepler Capital MarketsLower Price TargetBuyGBX 6,000 -> GBX 5,900View Rating Details
10/19/2015Bank of America Corp.Reiterated RatingNeutralGBX 6,000View Rating Details
5/18/2015XYZ ResearchReiterated RatingOutperformGBX 6,600View Rating Details
4/30/2015Charles StanleyReiterated RatingaccumulateView Rating Details
(Data available from 10/1/2014 forward)

Earnings

Earnings History for Shire PLC (LON:SHP)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Shire PLC (LON:SHP)
Current Year EPS Consensus Estimate: $4.32 EPS

Dividends

Dividend History for Shire PLC (LON:SHP)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/2/2016GBX 3.510.07%9/8/20169/8/201610/7/2016
2/11/2016GBX 15.320.44%3/10/20163/10/20164/12/2016
7/23/2015GBX 2.690.05%9/3/20159/3/201510/2/2015
7/18/2014GBX 2.240.04%9/3/20149/3/201410/3/2014
2/13/2014GBX 10.210.31%3/5/20143/5/20144/8/2014
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Shire PLC (LON:SHP)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/30/2016Dominic BlakemoreInsiderBuy133GBX 5,010£6,663.30
6/30/2016Bohuon,OlivierInsiderBuy134GBX 4,463£5,980.42
3/31/2016Bohuon,OlivierInsiderBuy133GBX 3,908£5,197.64
2/15/2016Bohuon,OlivierInsiderBuy1,000GBX 3,552£35,520
2/12/2016Burns,WilliamInsiderBuy1,250GBX 3,563£44,537.50
12/18/2015Burns,WilliamInsiderBuy156GBX 4,457£6,952.92
9/30/2015Blakemore ,DominicInsiderBuy129GBX 4,498£5,802.42
6/30/2015Kappler,David JInsiderBuy126GBX 51.05GBX 6,432.30
3/31/2015Susan KilsbyInsiderBuy375GBX 5,327£19,976.25
12/19/2014Steven GillisInsiderBuy228GBX 4,654£10,611.12
10/30/2014Steven GillisInsiderBuy381GBX 4,098£15,613.38
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Shire PLC (LON:SHP)
DateHeadline
4-traders.com logoSHIRE PLC : - Director/PDMR Shareholding (LON:SHP)
www.4-traders.com - September 30 at 2:30 PM
proactiveinvestors.co.uk logoShire: Not a dry eye in the house (LON:SHP)
www.proactiveinvestors.co.uk - September 29 at 12:42 PM
fool.co.uk logoDo today's results make this company a better buy than Shire plc? - Motley Fool UK (LON:SHP)
www.fool.co.uk - September 26 at 7:20 PM
4-traders.com logoShire : Closes Public Offering of Senior Notes (LON:SHP)
www.4-traders.com - September 23 at 11:57 AM
News IconShire PLC's Buy Rating Reiterated at Berenberg Bank (SHP) - Petro Global News 24 (LON:SHP)
petroglobalnews24.com - September 22 at 12:06 PM
investing.com logoU.K. stocks higher at close of trade; Investing.com United Kingdom 100 up 0.25% (LON:SHP)
www.investing.com - September 21 at 11:22 AM
uk.finance.yahoo.com logoAre these top healthcare stocks in your portfolio? (LON:SHP)
uk.finance.yahoo.com - September 21 at 11:22 AM
nasdaq.com logoShire Prices Public Offering Of Senior Notes - Quick Facts - Nasdaq (LON:SHP)
www.nasdaq.com - September 20 at 12:37 PM
News IconShire PLC (SHP) Price Target Raised to GBX 6050 at Jefferies Group - DailyQuint (LON:SHP)
dailyquint.com - September 20 at 12:37 PM
uk.finance.yahoo.com logoOrder book for Shire's M&A bond reach US$25bn: lead (LON:SHP)
uk.finance.yahoo.com - September 19 at 11:51 AM
finance.yahoo.com logoDistrict Court Issues Ruling in Hatch Waxman Case Regarding Shire's LIALDA® - Yahoo Finance (LON:SHP)
finance.yahoo.com - September 18 at 6:45 PM
News IconShire PLC (SHP) Earns Buy Rating from HSBC | NewsDen - NewsDen (LON:SHP)
newsden.net - September 17 at 6:45 PM
prnewswire.com logoDistrict Court Issues Ruling in Hatch Waxman Case Regarding Shire's LIALDA® - PR Newswire (press release) (LON:SHP)
www.prnewswire.com - September 16 at 7:00 PM
News IconShire Announces FDA Approval of Cuvitru [immune globulin subcutaneous (human)] for Primary Immunodeficiency (LON:SHP)
www.drugs.com - September 16 at 10:51 AM
News IconShire Announces U.S. FDA Approval of CUVITRU[TM] [Immune Globulin Subcutaneous (Human), 20% Solution] Treatment for Primary Immunodeficiency (LON:SHP)
www.medindia.net - September 15 at 7:23 PM
prnewswire.com logoShire Announces U.S. FDA Approval of CUVITRU[TM] [Immune Globulin Subcutaneous (Human), 20% Solution ... - PR Newswire (press release) (LON:SHP)
www.prnewswire.com - September 15 at 10:56 AM
News IconNetplay TV Plc (NPT) to Issue GBX 0.22 Dividend (LON:SHP)
thelakeandeswave.com - September 14 at 7:27 PM
News IconShire Announces U.S. FDA Approval of CUVITRUTM [Immune Globulin Subcutaneous (Human), 20% Solution] Treatment for Primary Immunodeficiency (LON:SHP)
www.prnewswire.co.uk - September 14 at 7:27 PM
News IconShire Plc (SHP) - Medical Equipment - Deals and Alliances Profile - New Market Research Report (LON:SHP)
reports.pr-inside.com - September 14 at 7:27 PM
directorstalkinterviews.com logoShire PLC 41.7% Potential Upside Indicated by Jefferies International - DirectorsTalk Interviews (LON:SHP)
www.directorstalkinterviews.com - September 12 at 6:51 PM
News IconShire Plc (LON:SHP) Receives Buy Rating From Jefferies Analysts - National Daily Press (LON:SHP)
www.nationaldailypress.com - September 12 at 6:51 PM
News IconShire to Participate at Two Upcoming Investor Conferences - PR Newswire UK (press release) (LON:SHP)
www.prnewswire.co.uk - September 8 at 6:58 PM
prnewswire.com logoShire to Participate at Two Upcoming Investor Conferences - PR Newswire (press release) (LON:SHP)
www.prnewswire.com - September 8 at 11:07 AM
ft.com logo[$$] Companies race to sell corporate debt in test of investor appetite (LON:SHP)
www.ft.com - September 6 at 7:26 PM
News IconHot Biotech Stocks Recap: Achillion Pharmaceuticals (NASDAQ:ACHN), Merrimack Pharmaceuticals (NASDAQ:MACK) - The Voice Registrar (LON:SHP)
voiceregistrar.com - September 6 at 12:01 PM
News IconSHIRE PLC - U.S. Securities and Exchange Commission filings (LON:SHP)
uk.advfn.com - September 5 at 6:24 PM
News IconDechra Pharmaceuticals plc Still Leads GlaxoSmithKline plc ... - Investomania (blog) (LON:SHP)
investomania.co.uk - September 5 at 11:22 AM
proactiveinvestors.co.uk logoUK shares close lower, wary of Fed speech, pharma dragged down by Clinton remarks (LON:SHP)
www.proactiveinvestors.co.uk - August 25 at 7:39 PM
investors.com logoMylan boss take the fight to Hillary (LON:SHP)
www.proactiveinvestors.com - August 25 at 12:30 PM
proactiveinvestors.co.uk logoShire leads the fallers as £3.7bn is wiped from drugs sector after Clinton blast (LON:SHP)
www.proactiveinvestors.co.uk - August 25 at 12:30 PM
capitalcube.com logoETF’s with exposure to Shire Plc : August 24, 2016 (LON:SHP)
www.capitalcube.com - August 24 at 7:06 PM
capitalcube.com logoShire Plc :SHP-GB: Earnings Analysis: Q2, 2016 By the Numbers : August 23, 2016 (LON:SHP)
www.capitalcube.com - August 23 at 11:55 AM
4-traders.com logoShire : Elections for the interim dividend (LON:SHP)
www.4-traders.com - August 19 at 7:15 PM
News IconSHIRE PLC - Elections for the interim dividend (LON:SHP)
uk.advfn.com - August 19 at 7:15 PM
publicnow.com logoElections for the interim dividend (LON:SHP)
www.publicnow.com - August 19 at 7:15 PM
publicnow.com logoElections for the interim dividend in ... (LON:SHP)
www.publicnow.com - August 19 at 7:15 PM
News IconSHIRE PLC - Half-year Report (LON:SHP)
uk.advfn.com - August 8 at 12:11 PM
ftsenews.co.uk logoShire PLC (LON:SHP) Issued With 'Buy' Rating At Jefferies ... - FTSE News (LON:SHP)
www.ftsenews.co.uk - August 5 at 10:27 AM
finance.yahoo.com logoEdited Transcript of SHP.L earnings conference call or presentation 2-Aug-16 1:00pm GMT (LON:SHP)
finance.yahoo.com - August 3 at 10:42 AM
finance.yahoo.com logoShire Delivers Strong Q2 2016 Revenue Growth; Upgrades Outlook (LON:SHP)
finance.yahoo.com - August 2 at 12:22 PM
nasdaq.com logoShire Plc Q2 Profit Tops Estimates; Updates 2016 Guidance (LON:SHP)
www.nasdaq.com - August 2 at 12:22 PM
breakingfinancenews.com logoUBS announced (LON:SHP) Shire Plc, increasing its stock price target to 5,200GBX earlier today (LON:SHP)
breakingfinancenews.com - August 2 at 12:22 PM
investors.com logoShire boosts savings target from Baxalta (LON:SHP)
www.proactiveinvestors.com - August 2 at 12:22 PM
nasdaq.com logoShire : FDA Approves BAXJECT III Reconstitution System For ADYNOVATE (LON:SHP)
www.nasdaq.com - August 1 at 12:02 PM
News IconShire Announces FDA Approval of adynovate with BAXJECT III Reconstitution System (LON:SHP)
www.medindia.net - August 1 at 12:02 PM
stockhouse.com logoSHIRE PLC - Total Voting Rights (LON:SHP)
www.stockhouse.com - August 1 at 12:02 PM
News IconLatest news on Shire (LON:SHP)
www.stockopedia.com - July 29 at 7:34 PM
breakingfinancenews.com logoShire PLC (LON:SHP) target price maintained at 5,500GBX as issued in a report today by Liberum Capital (LON:SHP)
breakingfinancenews.com - July 29 at 7:34 PM
ftsenews.co.uk logoExane BNP Paribas reiterated Shire Plc (LON:SHP) as 'Outperform' With 5700 PT - FTSE News (LON:SHP)
www.ftsenews.co.uk - July 28 at 10:40 AM
marketrealist.com logoHow Will Shire’s ADHD Franchise Perform in 2Q16? (LON:SHP)
marketrealist.com - July 27 at 9:12 AM

Social


Last Updated on 10/1/2016 by MarketBeat.com Staff